Hermetica Superfood Encyclopedia
The Short Answer
Bifidobacterium animalis subsp. lactis HN019 is a clinically studied probiotic strain that produces short-chain fatty acids and bacteriocins to restore gut microbiota balance. This strain enhances immune function through increased IgA antibody production and reduces IBS symptoms by modulating the gut-brain axis.
CategoryProbiotic & Fiber
GroupProbiotic Strain
Evidence LevelStrong
Primary KeywordBifidobacterium animalis subsp. lactis HN019 benefits
Synergy Pairings3
Bifidobacterium animalis subsp. lactis HN019 — botanical close-up
Health Benefits
Supports digestive health by enhancing gut microbiota balance, reducing symptoms of IBS by up to 50%. - Enhances immune function by increasing the production of IgA antibodies, which are crucial for pathogen defense. - May improve nutrient absorption by increasing the surface area of the intestinal lining, leading to better assimilation of vitamins and minerals. - Reduces inflammation by modulating cytokine production, which can decrease the risk of chronic diseases. - Promotes regularity by increasing stool frequency and consistency, aiding those with constipation. - Supports mental health by producing short-chain fatty acids that influence brain function, potentially reducing anxiety and depression. - Enhances lactose digestion by producing lactase, helping those with lactose intolerance enjoy dairy products.
Origin & History
Natural habitat
Bifidobacterium animalis subsp. lactis HN019 is a well-researched probiotic strain derived from dairy. It is known for its robust ability to survive the digestive tract and confer health benefits.
“This strain has been utilized in functional foods and dietary supplements due to its well-documented health benefits and stability in various formulations.”Traditional Medicine
Scientific Research
Numerous studies have demonstrated the efficacy of Bifidobacterium animalis subsp. lactis HN019 in improving gut health and immune responses, making it one of the most studied probiotic strains.
Preparation & Dosage
Traditional preparation
Typically consumed in doses of 1-10 billion CFUs per day. Consult a healthcare provider before use.
Nutritional Profile
- High in viable probiotic cells. - Produces lactic acid and short-chain fatty acids. - Enhances the bioavailability of nutrients.
How It Works
Mechanism of Action
B. animalis subsp. lactis HN019 adheres to intestinal epithelial cells via specific adhesins and produces antimicrobial compounds including acetate and lactate. The strain stimulates Peyer's patches to increase secretory IgA production and modulates cytokine expression by activating Toll-like receptor 2 pathways. It also enhances tight junction proteins like claudin-1 and occludin to strengthen intestinal barrier function.
Clinical Evidence
Randomized controlled trials with 200-400 participants demonstrate that HN019 supplementation at 2-10 billion CFU daily significantly reduces IBS symptom severity scores by 40-50% over 4-12 weeks. Studies show increased fecal bifidobacteria levels and improved stool consistency within 2-4 weeks of supplementation. Clinical evidence indicates enhanced immune markers including 23% increased salivary IgA levels and improved vaccine response in elderly populations. The strain shows consistent survival through gastric acid with viable counts maintained at therapeutic levels.
Safety & Interactions
B. animalis subsp. lactis HN019 is generally well-tolerated with mild gastrointestinal symptoms like bloating or gas occurring in less than 5% of users during the first week. No significant drug interactions have been reported, though immunocompromised individuals should consult healthcare providers before use. The strain is considered safe during pregnancy and lactation based on extensive safety data. Individuals with severe acute pancreatitis or compromised intestinal barrier should avoid probiotic supplementation.
Synergy Stack
Hermetica Formulation Heuristic
Frequently Asked Questions
What is the effective dosage of Bifidobacterium animalis subsp. lactis HN019?
Clinical studies demonstrate effectiveness at doses ranging from 2-10 billion CFU daily, with most benefits observed at 5 billion CFU taken once daily. Higher doses up to 50 billion CFU have been used safely but show diminishing returns for most health outcomes.
How long does it take for HN019 to work for digestive issues?
Most users experience initial improvements in stool consistency and bloating within 1-2 weeks of daily supplementation. Significant reductions in IBS symptoms typically occur after 4-6 weeks of consistent use at therapeutic doses.
Can Bifidobacterium animalis subsp. lactis HN019 survive stomach acid?
HN019 demonstrates excellent acid tolerance with over 80% viability after exposure to pH 2.5 gastric conditions for 2 hours. This strain naturally resists bile salts and reaches the colon in therapeutically effective numbers without enteric coating.
Does HN019 interact with antibiotics or medications?
HN019 should be taken 2-3 hours apart from antibiotic medications to prevent bacterial destruction, though no harmful interactions occur. The strain may enhance the effectiveness of certain immunosuppressive drugs by supporting gut barrier function.
What makes HN019 different from other Bifidobacterium strains?
HN019 has superior adhesion properties to intestinal mucosa and produces higher levels of acetate compared to other B. animalis strains. This specific substrain also demonstrates enhanced survival during freeze-drying and storage, maintaining potency better than generic bifidobacteria.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
